Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. While the world is striving for a treatment modality against SARS-CoV-2, our understanding about the virus entry mechanisms may help to design entry inhibitors, which may help to limit the virus spread...

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Rahul K. Suryawanshi, Chandrashekhar D. Patil, Raghuram Koganti, Sudhanshu Kumar Singh, Joshua M. Ames, Deepak Shukla
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	SARS-CoV-2 pseudotyped virus entry inhibitors cationic peptide heparan sulfate
Online Access:	https://www.mdpi.com/2076-0817/10/7/803